Latest Publications

Share:

OIG Releases Updated Provider Self-Disclosure Protocol

On April 17, 2013, the Office of the Inspector General (OIG) of the United States Department of Health and Human Services released an updated Provider Self-Disclosure Protocol (SDP). As self-described, OIG updated the SDP to...more

5/21/2013 - Disclosure Requirements Eligibility OIG Self-Disclosure Requirements Transparency

"Ranbaxy Resolves Criminal and Civil Charges Through Record Settlement"

Executive Summary - On May 13, 2013, generic drug manufacturer Ranbaxy USA Inc. (Ranbaxy), a subsidiary of Indian generic drug manufacturer Ranbaxy Laboratories Limited, pled guilty to seven felony charges as part of a...more

5/15/2013 - Civil Monetary Penalty Criminal Sanctions False Claims Act FDA FDCA Penalties Settlement

2 Results
|
View per page
Page: of 1